Diem Nguyen, Ph.D., M.B.A. is Chief Executive Officer and Director at SIGA. She was appointed in January 2024. Most recently, Dr. Nguyen served as CEO of Xalud Therapeutics, a clinical …

Diem Nguyen is Chief Executive Officer and Director at SIGA. She was appointed in January 2024. Most recently, Dr. Nguyen served as CEO of Xalud Therapeutics, a clinical stage …

2024年1月22日 · SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Diem …

2024年1月22日 · As CEO, Dr. Nguyen will lead SIGA’s ongoing efforts in the development, manufacture and global distribution of antiviral therapies for the treatment of infectious …

NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today …

Diem Nguyen has more than 25 years of experience and extensive expertise in the pharmaceutical industry. She is currently the CEO of SIGA Technologies, a public commercial …

2024年1月23日 · Siga Technologies Inc. (NASDAQ:SIGA) named Die m Nguyen to succeed Phil Gomez as CEO, effective Jan. 27. Nguyen was CEO of Xalud Therapeutics Inc. and served as …

2025年1月2日 · SIGA Technologies has announced the appointment of Dr. Diem Nguyen as its new CEO, effective January 27, 2024, marking a leadership transition as Dr. Phil Gomez …

Diem Nguyen, Ph.D., is the CEO of SIGA Technologies, Inc., a biopharmaceutical company focused on developing treatments for serious infectious diseases. Dr. Nguyen s leadership is …

SIGA Technologies' CEO is Diem Nguyen, appointed in Jan 2024, has a tenure of 1.17 years. directly owns 0.095% of the company’s shares, worth $398.46K. The average tenure of the …